PRKAA1 and hepatocellular carcinoma: These data demonstrated that FATP5 depletion enhances the tumorigenic capacity of HCC cells in vivo, while activation of the AMPK pathway by metformin abolishes these effects, implying an essential role of AMPK in regulating FATP5-mediated inhibition of HCC progression and metastasis.